Morphogenetic effects of neuregulin (neu differentiation factor) in cultured epithelial cells.

Neuregulin, or neu differentiation factor, induces cell proliferation or differentiation through interaction with members of the ErbB family of receptor tyrosine kinases. We report that neuregulin can also induce profound morphogenic responses in cultured epithelial cells of different origins. These effects include scattering of small epithelial islands and rearrangement of larger cell islands into ordered ring-shaped arrays with internal lumens. The ring-forming cells are interconnected by cadherin- and beta-catenin-containing adherens junctions. In confluent cultures, neuregulin treatment induces formation of circular lumenlike gaps in the monolayer. Both cell scattering and ring formation are accompanied by a marked increase in cell motility that is independent of hepatocyte growth factor/scatter factor and its receptor (c-Met). Affinity-labeling experiments implied that a combination of ErbB-2 with ErbB-3 mediates the morphogenic signal of neuregulin in gastric cells. Indeed, a similar morphogenic effect could be reconstituted in nonresponsive cells by coexpression of ErbB-2 and -3. We conclude that a heterodimer between the kinase-defective neuregulin receptor, ErbB-3, and the coreceptor, ErbB-2, mediates the morphogenetic action of neuregulin.

[1]  G. V. Vande Woude,et al.  Met-HGF/SF: tumorigenesis, invasion and metastasis. , 2007, Ciba Foundation symposium.

[2]  A. Ridley,et al.  Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. , 1998, Molecular biology of the cell.

[3]  D. Riethmacher,et al.  The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system. , 1998, Genes & development.

[4]  Y. Yarden,et al.  The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. , 1998, Biochimica et biophysica acta.

[5]  G. Frantz,et al.  ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. , 1997, Development.

[6]  J. Verweij,et al.  Abrogated energy-dependent uptake of cisplatin in a cisplatin-resistant subline of the human ovarian cancer cell line IGROV-1 , 1997, Cancer Chemotherapy and Pharmacology.

[7]  D. Riethmacher,et al.  Severe neuropathies in mice with targeted mutations in the ErbB3 receptor , 1997, Nature.

[8]  Kenneth M. Yamada,et al.  The Zinc-Finger Protein Slug Causes Desmosome Dissociation, an Initial and Necessary Step for Growth Factor–induced Epithelial–Mesenchymal Transition , 1997, The Journal of cell biology.

[9]  Yosef Yarden,et al.  Neuregulins and Their Receptors: A Versatile Signaling Module in Organogenesis and Oncogenesis , 1997, Neuron.

[10]  P. Comoglio,et al.  Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors. , 1997, Cytokine & growth factor reviews.

[11]  David A. Cheresh,et al.  Regulation of Cell Motility by Mitogen-activated Protein Kinase , 1997, The Journal of cell biology.

[12]  L. Cantley,et al.  Met -/- kidneys express epithelial cells that chemotax and form tubules in response to EGF receptor ligands. , 1997, The American journal of physiology.

[13]  W. Birchmeier,et al.  Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis , 1996, Nature.

[14]  C. Nobes,et al.  Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways , 1996, Current Biology.

[15]  Y. Yarden,et al.  A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor , 1996, Molecular and cellular biology.

[16]  D. Stern,et al.  Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[17]  E. Anton,et al.  Glial Growth Factor 2, a Soluble Neuregulin, Directly Increases Schwann Cell Motility and Indirectly Promotes Neurite Outgrowth , 1996, The Journal of Neuroscience.

[18]  M. Tansey,et al.  ARIA/HRG regulates AChR epsilon subunit gene expression at the neuromuscular synapse via activation of phosphatidylinositol 3-kinase and Ras/MAPK pathway , 1996, The Journal of cell biology.

[19]  M. Sachs,et al.  Motogenic and morphogenic activity of epithelial receptor tyrosine kinases , 1996, The Journal of cell biology.

[20]  G. Bokoch,et al.  Rac GTPase interacts specifically with phosphatidylinositol 3-kinase. , 1996, The Biochemical journal.

[21]  Kuo-Fen Lee,et al.  Requirement for neuregulin receptor erbB2 in neural and cardiac development , 1995, Nature.

[22]  Rüdiger Klein,et al.  Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor , 1995, Nature.

[23]  Carmen Birchmeier,et al.  Multiple essential functions of neuregulin in development , 1995, Nature.

[24]  W. Birchmeier,et al.  Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland , 1995, The Journal of cell biology.

[25]  L. Cantley,et al.  Heregulin Stimulates Mitogenesis and Phosphatidylinositol 3-Kinase in Mouse Fibroblasts Transfected with erbB2/neu and erbB3(*) , 1995, The Journal of Biological Chemistry.

[26]  G F Pierce,et al.  Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds. , 1995, The Journal of clinical investigation.

[27]  L. Orci,et al.  Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. , 1995, Journal of cell science.

[28]  E. Peles,et al.  ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. , 1994, The Journal of biological chemistry.

[29]  W. Grizzle,et al.  Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. , 1994, Journal of the National Cancer Institute.

[30]  P. Clark,et al.  Modulation of scatter factor/hepatocyte growth factor activity by cell-substratum adhesion. , 1994, Journal of cell science.

[31]  G. V. Vande Woude,et al.  The Met proto-oncogene mesenchymal to epithelial cell conversion. , 1994, Science.

[32]  T. Nakamura,et al.  Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[33]  K. Matsumoto,et al.  Effect of hepatocyte growth factor on cadherin-mediated cell-cell adhesion. , 1993, Cell structure and function.

[34]  G. V. Vande Woude,et al.  The met proto-oncogene receptor and lumen formation. , 1992, Science.

[35]  Y. Yarden,et al.  Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation. , 1992, The Journal of biological chemistry.

[36]  L. Orci,et al.  Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor , 1991, Cell.

[37]  A. Bardelli,et al.  Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. , 1991, The EMBO journal.

[38]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[39]  R. Jensen,et al.  Characteristics of cell lines established from human gastric carcinoma. , 1990, Cancer research.

[40]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[41]  A. Ullrich,et al.  HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. , 1989, The EMBO journal.

[42]  H. Lehväslaiho,et al.  A chimeric EGF‐R‐neu proto‐oncogene allows EGF to regulate neu tyrosine kinase and cell transformation. , 1989, The EMBO journal.

[43]  J. Schlessinger,et al.  Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. , 1988, The Journal of biological chemistry.

[44]  Michael Stoker,et al.  Scatter factor is a fibroblast-derived modulator of epithelial cell mobility , 1987, Nature.

[45]  Y. Yarden,et al.  Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. , 1987, Biochemistry.

[46]  M. Radu,et al.  Establishment and characterization of a cell line of human breast carcinoma origin. , 1979, European journal of cancer.

[47]  D. Paulson,et al.  Isolation of a human prostate carcinoma cell line (DU 145) , 1978, International journal of cancer.

[48]  E. C. Pielou,et al.  An introduction to mathematical ecology , 1970 .

[49]  E. Hay An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[50]  J. Thiery,et al.  Modulations of the epithelial phenotype during embryogenesis and cancer progression. , 1994, Cancer treatment and research.

[51]  J. Thiery,et al.  Involvement of cell motility in tumor progression. , 1993, Symposia of the Society for Experimental Biology.

[52]  M. Sharpe,et al.  Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells. , 1993, Symposia of the Society for Experimental Biology.

[53]  John Philip Trinkaus,et al.  Cells into Organs: The Forces That Shape the Embryo , 1984 .

[54]  E. J. Ambrose,et al.  CELL MOVEMENTS. , 1965, Endeavour.